炎症性腸疾患治療市場の成長、規模、シェア、傾向、主要プレーヤーの分析、2031年までの予測

  • Report Code : TIPRE00003491
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

炎症性腸疾患治療の市場価値は、2023 年の 240.5 億米ドルから 2031 年には 316.7 億米ドルに成長すると予測されており、2023 年から 2031 年にかけて市場は 3.50% の CAGR を記録すると予想されています。

市場分析とアナリストの見解:

炎症性腸疾患 (IBD) は、クローン病や潰瘍性大腸炎などの消化管の慢性炎症性疾患です。これらの疾患は消化管の内壁に炎症を引き起こし、腹痛、下痢、疲労、体重減少などの症状を引き起こします。治療は、薬物療法、生活習慣の変更、場合によっては手術によって、炎症を軽減し、症状を管理し、合併症を予防することを目的としています。 IBD の管理には通常、寛解を維持し生活の質を向上させるための継続的な医療とモニタリングが必要です。炎症性腸疾患治療市場の成長を牽引する主な要因は、クローン病と潰瘍性大腸炎の有病率の上昇と、製品発売数の増加です。このレポートには、現在の炎症性腸疾患治療市場の傾向と予測期間中の予測可能な影響による成長見通しが含まれています。技術の進歩は、今後数年間で炎症性腸疾患治療市場に大きなトレンドをもたらす可能性があります。さらに、継続的な研究による革新的な治療法の開発や政府の取り組みの奨励も、市場の成長を促進すると予想されます。

成長の原動力と課題:

クローン病は、主に消化器系に影響を及ぼす複雑な慢性疾患です。国立医学図書館によると、2023年には10万人あたり825件のIBD症例があり、これにはクローン病の410件、潰瘍性大腸炎およびIBD-uの414件が含まれます。有病率は0.82%で、2023年には322,600人のカナダ人がIBDに罹患していました。胃腸疾患の患者は、診断検査の絶食要件、治療上の食事制限、食欲不振による食欲不振、または疾患自体に起因する栄養要件の変化により、栄養状態が悪化するリスクが高くなります。したがって、胃腸疾患患者には経腸栄養が処方されます。必要な栄養素を供給するには経腸経路が好まれるためです。したがって、クローン病と潰瘍性大腸炎の有病率の上昇は、炎症性腸疾患治療市場の成長を促進します。

クローン病、外傷による胃腸疾患、腸閉塞(BO)、顕微鏡的大腸炎、短腸症候群、および潰瘍性大腸炎は、一般的な胃腸疾患の一部です。 2021年にHealthlineに掲載された記事によると、世界中の約40%の人々が機能性胃腸障害の影響を受けています。 カナダ消化器健康財団によると、何百万人ものカナダ人が消化器疾患を抱えて生活しており、毎年約2,000万人のカナダ人、つまり3人に2人が消化器疾患に苦しんでいます。

一方、炎症性腸疾患(IBD)の治療に関連する高額な費用は、IBD治療市場における大きな障壁となっています。高価な医薬品から頻繁な入院や手術まで、炎症性腸疾患(IBD)の管理は患者と医療制度に大きな経済的負担をかける可能性があります。コスト要因により、IBDを患う多くの人々が最適なケアや革新的な治療を受けられないことがよくあります。手頃な価格とアクセスの問題に対処することは、この慢性疾患に苦しむ患者の転帰と生活の質を改善するために不可欠です。したがって、治療に伴う高額な費用は、炎症性腸疾患治療市場の成長を妨げています。

レポートのセグメンテーションと範囲:

炎症性腸疾患治療市場の分析は、薬物クラス、疾患の適応症、流通チャネルという次のセグメントを考慮して実施されました。地理に基づいて、炎症性腸疾患治療市場は、北米(米国、カナダ、メキシコ)、ヨーロッパ(英国、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパ)、アジア太平洋(中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋)、中東およびアフリカ(UAE、サウジアラビア、南アフリカ、その他の中東およびアフリカ)、南米および中米(ブラジル、アルゼンチン、その他の南米および中米)に分類されています。

セグメント分析:

薬物クラスに基づく洞察

薬物クラスに基づいて、市場は生物学的製剤、アミノサリチル酸、コルチコステロイド、その他に分類されています。バイオロジクスセグメントは、2023年に炎症性腸疾患治療市場で最大のシェアを占め、2023年から2031年の間に最高のCAGRを記録すると予想されています。

疾患の兆候に基づく洞察

疾患の兆候に基づいて、炎症性腸疾患治療市場はクローン病と潰瘍性大腸炎に分かれています。クローン病セグメントは、2031年までにかなりの市場シェアを占めると予想されています。

疾患の兆候に基づく洞察

流通チャネルに基づいて、市場は病院薬局、小売薬局、オンライン薬局に分類されます。病院薬局セグメントは、2031年までに炎症性腸疾患治療市場で大きなシェアを占めると予想されています。

地域分析:

炎症性腸疾患治療市場レポートの地理的範囲は、北米、ヨーロッパ、アジア太平洋、中東およびアフリカ、南米および中米を網羅しています。2023年には、北米が最大の市場シェアを占めました。米国は北米で最大の収益シェアで市場を支配しています。この国で拡大している炎症性腸疾患治療市場規模の理由は、炎症性疾患の有病率の上昇、主要な市場プレーヤーの存在、およびそれらの戦略的イニシアチブによるものです。支払いソリューションの改善、治療率の高さ、革新的な医薬品の処方の増加、途切れることのない研究努力、および政府の好ましい取り組みも、米国およびその他の北米諸国の炎症性腸疾患治療市場に利益をもたらします。クローン病および/またはColitis Foundation は、大腸炎とクローン病の治療を目的とした臨床研究とトランスレーショナル リサーチの促進に取り組んでいる注目すべき組織の 1 つです。

競合状況と主要企業:

このレポートで提示された炎症性腸疾患治療市場の予測は、この市場の利害関係者が成長戦略を計画するのに役立ちます。AbbVie Inc、Takeda Pharmaceutical Company Limited、Pfizer Inc、Biogen、Novartis AG、Lilly、UCB SA、CELLTRION INC.、Merck & Co., Inc.、Johnson & Johnson Services, Inc. は、炎症性腸疾患治療市場レポートで紹介されている主要企業の一部です。これらの企業は、世界中で高まる消費者の需要を満たすために、提供内容の拡大に重点を置いています。グローバルなプレゼンスにより、多くの顧客にサービスを提供でき、結果として市場でのプレゼンスを拡大できます。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which drug class segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on drug class, the market is segmented into biologics, aminosalicyclates, corticosteroids, and others. The biologics segment held the largest Inflammatory Bowel Disease Treatment Market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.

Which disease indication segment dominates the Inflammatory Bowel Disease Treatment Market?

Based on disease indication, the Inflammatory Bowel Disease Treatment Market is segmented into crohn's disease and ulcerative colitis. The crohn's disease segment is anticipated to hold a significant share by 2031.

What was the estimated Inflammatory Bowel Disease Treatment Market size in 2023?

The Inflammatory Bowel Disease Treatment Market was valued at US$ 24.05 billion in 2023.

What are the growth estimates for the Inflammatory Bowel Disease Treatment Market till 2031?

The Inflammatory Bowel Disease Treatment Market is expected to be valued at US$ 31.67 billion in 2031.

Who are the major players in the Inflammatory Bowel Disease Treatment Market?

The Inflammatory Bowel Disease Treatment Market has major market players, including AbbVie Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc, Biogen, Novartis AG, Lilly, UCB S.A., CELLTRION INC., Merck & Co., Inc., and Johnson & Johnson Services, Inc.

What factors drive the Inflammatory Bowel Disease Treatment Market?

The key factors driving the Inflammatory Bowel Disease Treatment Market growth are the rising prevalence of crohn's disease and ulcerative colitis and increasing product launches over the projection period. Inflammatory Bowel Disease Treatment Market trends include the technological advancement in IBD treatment. Furthermore, the development of innovative treatments through continuing research as well as encouraging government initiatives are also expected to fuel the market growth.

What is inflammatory bowel disease?

Inflammatory bowel disease" (IBD) is a chronic inflammatory condition of the gastrointestinal tract, including Crohn's disease and ulcerative colitis. These conditions cause inflammation of the digestive tract lining, leading to symptoms like abdominal pain, diarrhea, fatigue, and weight loss. Treatment aims to reduce inflammation, manage symptoms, and prevent complications through medication, lifestyle changes, and sometimes surgery. Managing IBD typically requires ongoing medical care and monitoring to maintain remission and improve quality of life.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies - Inflammatory Bowel Disease Treatment Market

  1. AbbVie Inc
  2. Takeda Pharmaceutical Company Limited
  3. Pfizer Inc
  4. Biogen
  5. Novartis AG
  6. Lilly
  7. UCB S.A.
  8. CELLTRION INC.
  9. Merck & Co., Inc.
  10. Johnson & Johnson Services, Inc.
  11. Mindray Medical International Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.